Division of Preventive Medicine

Department of Family and Preventive Medicine


Matthew A. Allison, MD, MPH is Professor and Interim Chief, Division of Preventive Medicine in the Department of Family Medicine and Public Health at the University of California San Diego. Dr. Allison earned his undergraduate degree in Biochemistry from the California Polytechnic State University and a Doctorate in Medicine from the Uniformed Services University. After medical school, and a categorical internship at the Naval Medical Center San Diego, he was trained and certified as a US Navy Diving and Undersea Medical Officer and then served in this capacity for 3 tours of duty. Towards the end of his military service, Dr. Allison obtained a Master’s degree in Public Health Epidemiology from San Diego State University (SDSU). Then, he completed residency training in Public Health and General Preventive Medicine (focused on preventive cardiology) and a postdoctoral fellowship in cardiovascular epidemiology, both at the University of California San Diego (UCSD). He is board certified in Public Health and General Preventive Medicine by the American College of Preventive Medicine and is a Fellow of the American Heart Association (FAHA).

In 2005, Dr. Allison joined the faculty in the Department of Family and Preventive Medicine at UCSD and was promoted to Professor with Tenure in 2013. Currently, he conducts research that broadly investigates the prevention of cardiovascular diseases, with specific focal areas to include subclinical atherosclerosis, metabolism and body composition, kidney disease, women’s health and racial/ethnic disparities. In this regard, he is the Director of the UCSD Women’s Cardiovascular Health Research Center, the Carotid Ultrasound Reading Center, the UCSD-SDSU MD-MPH program and the Center of Excellence in Cardiovascular Epidemiology and Prevention, while also being the Associate Director of the UCSD Integrated Fellowship on the Prevention of Cardiovascular Diseases. He has received postdoctoral fellowship and career transition awards from the American Heart Association, as well as three R01’s and one R21 from the NIH. He has been the subcontract principal investigator for over 12 NIH funded studies. He is an active investigator to the Women’s Health Initiative, Multi-Ethnic Study of Atherosclerosis and the Hispanic Community Health Study – Study of Latinos. Dr. Allison currently serves as a Guest/Consulting Editor to the Circulation suite of journals and is on the editorial boards for Arteriosclerosis, Thrombosis and Vascular Biology, and Vascular Medicine. He has also served on several NIH study section committees and special emphasis panels. He has published nearly 300 manuscripts and book chapters.

Since 2011, Dr. Allison has been the Director of the Non-Invasive Vascular Laboratory and a staff physician in the Department of Surgery; both at the Veteran’s Affairs San Diego Healthcare System.

Cheryl A. M. Anderson, PhD, MPH, MS is an Associate Professor in the Department of Family Medicine and Public Health. Dr. Anderson received her doctoral degree from the University of Washington, and her Master of Public Health degree from the University of North Carolina at Chapel Hill. At UCSD, Dr. Anderson is a member of the Cardiovascular Epidemiology and Prevention Center of Excellence, as well as the Health Behavior Change in Underserved and Vulnerable Populations Center of Excellence. 

Dr. Anderson's research focuses on nutrition and chronic disease prevention. She is an active researcher in cardiovascular epidemiology, and is the principal investigator of an NHLBI-funded study of the effects of dietary sodium and potassium intake on cardiovascular disease. She is the also the principal investigator of a behavioral intervention study for adherence to current dietary sodium recommendations. She is a co-investigator on the NIDDK-funded national multicenter Chronic Renal Insufficiency Cohort Study, which aims to identify risk factors and mechanisms of progressive renal disease and cardiovascular events in individuals with chronic kidney disease.

Dr. Anderson is a Fellow of the American Heart Association, and is a member of the leadership committee of the American Heart Association's councils on Epidemiology and Nutrition Physical Activity and Metabolism. She is also a member of the Pan American Health Organization’s (PAHO) Expert Group on Cardiovascular Disease Prevention through Dietary Salt Reduction, and the World Health Organization’s International Agency for Research on Cancer (IARC) committee on nutrition and physical (in)activity as determinants of cancer risk in Africa. She has also served on committees of the institute of Medicine (IOM), and in 2011 was appointed to the IOM’s standing Food and Nutrition Board. Additional honors and awards include the prestigious Gil Omenn Award for Academic Excellence (2001), Dannon Nutrition Leadership Institute Scholar (2003), and a Volunteer Service Award from the National Kidney Foundation of Maryland (2010).

Vibha Bhatnagar, MD, MPH is a family medicine physician and clinical epidemiologist with diverse clinical and research experience. Her research focuses on analyzing cohort studies and developing analytic databases from electronic medical records. This work includes analysis of genetic determinants of complex diseases such as hypertension and chronic kidney disease.


Ryan Bradley, ND, MPH is an Adjunct Assistant Professor in the Department of Family Medicine and Public Health. Dr. Bradley received his Doctor of Naturopathy degree from Bastyr University and his Master of Public Health degree from the University of Washington. At UCSD, Dr. Bradley is a member of the Center of Excellence on Research and Training in Integrative Health Research Committee, the Krupp Endowment Research Committee, and is a faculty and mentor for the Arterial Research T32 program.

Dr. Bradley’s clinical research focuses on diet, nutrition, natural products and complementary/integrative health in the context of cardiometabolic disease. He is also an active investigator in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort related to gamma-glutamyltransferase (GGT) as a biomarker of glutathione demand in the context of cardiometabohepatic risk, and differential risk prediction of coronary artery calcium density vs. volume.


Michael H. Criqui, MD, MPH is Distinguished Professor, Division of Preventive Medicine, in the Department of Family Medicine and Public Health at the University of California, San Diego (UCSD) School of Medicine. He also holds a joint appointment as Distinguished Professor, Division of Cardiology, in the Department of Medicine at UCSD. Dr Criqui received his MD and did his residency training at the University of California, San Francisco and received his MPH in epidemiology from the University of California, Berkeley. He is Board Certified in General Preventive Medicine by the American College of Preventive Medicine.

Dr. Criqui is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of subclinical atherosclerosis, peripheral arterial disease, and peripheral venous disease.  He has published over 500 manuscripts and book chapters, and has been an invited lecturer at numerous national and international medical meetings.  He is the recipient of several research grants and contracts, and is currently the Director of the NHLBI funded T32 training program at UCSD in cardiovascular epidemiology and prevention.  He has mentored numerous students, residents and fellows.

Dr. Criqui is a Fellow of the following societies: the American College of Preventive Medicine, the American College of Epidemiology, the Society for Vascular Medicine, the Council on Peripheral Vascular Disease of the American Heart Association (AHA), and the Council on Epidemiology and Prevention of the AHA , for which he served as Chair.  He is past Chair of the Interdisciplinary Committee on Prevention for the AHA.  He currently chairs the International Peripheral Arterial Disease Working Group, for the Global Burden of Diseases, Injuries, and Risk Factors Study.  He has served on committees for the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control, the World Health Organization, and the Institute of Medicine.  

He is the recipient of several honors including election to the American Epidemiological Society (1984), the Joseph E. Stokes III Preventive Cardiology Award from the American Society for Preventive Cardiology (2001), the Frederick H. Epstein Memorial Lecture Award from the European Society of Cardiology Working Group on Epidemiology and Prevention (2002), the Special Recognition Award from AHA Council on Epidemiology and Prevention (2004), the Distinguished Achievement Award from the AHA Council on Epidemiology and Prevention (2008), the President’s Award for Vision  from the Vascular Disease Foundation (2010), the Marcus Award for Distinguished Contribution as a Gifted Teacher from the International Academy of Cardiology (IAC) (2011), the IAC Distinguished Fellowship award (2013, and the Ancel Keys Memorial Lecturer Award from the AHA.   In 2010, he was named a Distinguished Scientist of the American Heart Association, the organization’s highest scientific award.  

Amelia Eastman, DO is an Assistant Clinical Professor.  She attended medical school at Western University of Health Sciences and completed residencies in physical medicine and rehabilitation at Baylor College of Medicine, and in preventive medicine at UC San Diego. She is board-certified in the fields of physical medicine and rehabilitation, as well as in preventive medicine. Additionally, Dr. Eastman is a member of the Exercise and Physical Activity Resource Center (EPARC) at the California Institute for telecommunications and Information Technology, and a reviewer for the American Journal of Preventive Medicine. Dr. Eastman's research interest include sports concussion, back pain in workers, and validating objective physical activity and performance measures. She is involved in numerous research trials in the areas of pain, functional decline, fall prevention, and exercise, and has two patents pending for medical inventions to improve functional performance.  Before attending medical school, Dr. Eastman worked as a professional mountain and river guide in South America and New Zealand. In addition, she has lived and worked in health care in Africa and Australia.

Robert A. Gunn, MD, MPH obtained his medical degree (MD) from Yale University (1966), a Masters in Public Health (MPH) in epidemiology from UCLA (1975), and a Diploma of Tropical Medicine and Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine (1974). He is Board Certified in Preventive Medicine (1979). Dr. Gunn has worked in local, state and federal governments in public health focusing mainly on infectious disease prevention and control. He served as a Commissioned Officer in the US Public Health Service (USPHS) at the Centers for Disease Control and Prevention (CDC) and was assigned to the San Diego County Public Health Department in 1991.

Dr. Gunn joined the UCSD Department of Family Medicine and Public Health in 1993 and is currently an Adjunct Professor Emeritus, Division of Preventive Medicine. He has published numerous articles about sexually transmitted infections (STDs, HIV, and viral hepatitis). His current interests involve integration of prevention services into routine medical care.

Linda L. Hill, MD, MPH is a Clinical Professor in the Department of Family Medicine and Public Health at UCSD, and the Director of the UCSD/SDSU General Preventive Medicine Residency. San Diego Family Care, a Federal 330 Community Health Center, is the site of her clinical activities, as Medical Director 1980 to 2001, and Senior Staff Physician since 2001. She is the Director of the Training, Research and Education for Driving Safety (TREDS), a nationally recognized driving safety center. She is the Medical Director of the Exercise and Physical Activity Resource Center (EPARC), providing services to researchers, individuals, and physicians on physical activity, exercise prescriptions, body composition assessments, weight management, bone health and balance. She is the Co-Director of the UCSD Injury Epidemiology Prevention and Research Center, and Medical Director of the Refugee Health Assessment Program. She is engaged in prevention research and teaching with current/past support from the California Office of Traffic Safety, AAA Foundation for Older Driver Safety, Robert Wood Johnson, American Cancer Society, and Health Services Resource Administration, and the NIH including research in injury prevention, obesity, decision making, compliance, physician training, and refugee health. In addition to her teaching activities with the preventive medicine residents, she mentors and precepts medical students, masters students, pre-doctoral students and undergraduates. Her hobbies include classical piano and ocean sports.
Joachim H. Ix, MD, MAS is a nephrologist and clinical investigator at the University of California, San Diego.  Dr. Ix is currently  Professor of Medicine and Chief of the Division of Nephrology-Hypertension in the Department of Medicine and holds a joint appointment with the Veterans Affairs San Diego Healthcare System in La Jolla, California.

Dr. Joachim Ix's primary research interest is to delineate how metabolic complications of chronic kidney disease contribute to cardiovascular disease.  His research focuses on aberrant regulation of calcium, phosphate, and associated regulatory hormones in the setting of chronic kidney disease.  He has evaluated their relationships with vascular calcium deposition, arterial stiffness, cardiac structural changes, and cardiovascular disease events.  He is also interested in the relationship of aberrant mineral metabolism with bone disease and with the rate of progression of chronic kidney disease and  has used large scale datasets to understand these relationships in different observational settings.  Dr. Ix is particularly interested in identifying novel therapies to intervene on altered mineral metabolism in chronic kidney disease patients.  He has tested novel therapies using small scale, cross-over studies that involve intensive monitoring in general clinical research study (GCRC) settings.  More recently, he is leading larger scale multi-center randomized placebo controlled studies testing novel therapies in chronic kidney disease patients.

Deborah Kado MD, MS is Professor at the University of California, San Diego School of Medicine. She is an internist and geriatrician with a primary research focus on osteoporosis and the related disorder hyperkyphosis. She is a successfully funded National Institute's of Health researcher and is internationally recognized in her field of expertise. Dr. Kado graduated from Cornell University Medical College, completed her residency in internal medicine, served as chief resident, and then did post-residency fellowships in clinical research at UCSF and in geriatrics at UCLA. She subsequently completed a Master of Sciences Degree in Epidemiology at the UCLA School of Public Health.  Dr. Kado serves as the Deputy Director of Clinical Research and Education for the Stein Institute for Research on Aging and also is the Osteoporosis Clinic Director for the UCSD Health System.  Dr. Kado has a joint appointment in the Division of Preventive Medicine, Department of Family Medicine and Public Health and the Division of Endocrinology, Department of Medicine, and is an associate member of the UC San Diego Moores Cancer Center.   

Elena Martinez, PhD is a Professor in the Department of Family and Preventive Medicine, having joined the UC San Diego faculty in 2012. She holds the Sam M. Walton Endowed Chair for Cancer Research and Co-leads the Reducing Cancer Disparities Program at the Moores Cancer Center. Dr. Martinez holds a PhD in Epidemiology and a Master’s in Public Health. Dr. Martinez’s research interests in colorectal cancer prevention began during the conduct of her doctoral dissertation and extended into her post-doctoral studies at the Harvard School of Public Health. Prior to joining the UC San Diego faculty, she was Professor of Epidemiology in the Mel and Enid Zuckerman College of Public Health and was the Richard H. Hollen Professor of Cancer Prevention at the Arizona Cancer Center. She had a very active research portfolio at the University of Arizona, including RO1 funding and program leadership in a Program Project (PO1) and a Specialized Program of Research Excellence (SPORE) program. She has published extensively in areas of epidemiology, molecular epidemiology, and cancer prevention. Her research currently focuses on breast cancer in Hispanic women, with a prominent leadership role in the Ella Binational Breast Cancer Study. She is currently co-PI of an NCI-funded UO1 grant assessing epidemiologic and epigenetic features of breast tumors occurring in the post-partum period in Hispanic women. In addition, she is a key member of the original investigative team that implemented a large Gates Foundation-funded consortium in six countries in Latin America focusing on Helicobacter pylori eradication and gastric cancer prevention. Nationally, she has established herself as a strong leader in the area of cancer health disparities; evidence of this is her appointment as recent chair of the American Association for Cancer Research Minorities in Cancer Research Council. In addition, she is senior editor of the Cancer Disparities section for the Cancer Epidemiology Biomarkers and Prevention journal. Dr. Martinez was a recipient of the 2013 Women Who Mean Business Award from the San Diego Business Journal. Dr. Martinez has served on the NCI’s Board of Scientific Counselors and currently she is a member of the Institute’s Board of Scientific Advisors.
Bilge Pakiz, EdD is a Project Scientist.  Based on her extensive experience in operationalizing community-based research projects, Dr. Pakiz has collaborated with investigators at the Cancer Prevention and Control Program at the UC San Diego Moores Cancer Center and has assisted them with the overall conduct of a number of clinical trials that focus on obesity, behavioral weight loss interventions, and behavioral and metabolic factors associated with disease risk. She is the project director of the UCSD TREC (Transdisciplinary Research on Energetics and Cancer) Center, one of four TREC centers across the US funded by the National Institutes of Health (NIH). The UCSD TREC Center includes four studies that focus on mechanisms linking obesity with breast cancer risk investigate obesity and lifestyle factors related to insulin resistance and inflammation, using mouse models and clinical trials. One of the three TREC clinical trials is the Diet Composition and Genetics: Effects on Weight, Inflammation and Biomarkers study. This project involves a 12-month behavioral weight loss program with 245 obese women assigned to three study arms with different dietary composition. The results will help to refine dietary guidance for optimal weight control and breast cancer prevention and will contribute to knowledge of mechanisms that link insulin resistance, inflammation and obesity to breast cancer risk and progression. Dr. Pakiz also was a Co-Investigator for the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study, funded by the National Institutes of Health (NIH).  This was a 4-year, multi-site randomized clinical trial of 693 overweight/obese breast cancer survivors, designed to demonstrate the feasibility of achieving sustained weight loss and to examine the impact of weight loss on quality of life and co-morbidities. Other recent studies she has directed include an industry-sponsored trial that tested whether providing portion-controlled prepackaged lunch and dinner entrées in the context of a reduced-energy diet prescription and behavioral counseling promotes greater weight loss in overweight and obese men and women (N=183), compared to control conditions where the prescribed diet is consumed via self-selected foods.

Kevin Patrick, MD, MS is Professor and Director of the Center for Wireless and Population Health Systems at the Qualcomm Institute/Calit2. He is also Director of the Health Data Exploration project of the Robert Wood Johnson Foundation. He served as Editor-in-Chief of the American Journal of Preventive Medicine for 20 years (1994-2013), and has served on the Secretary's Council for Health Promotion and Disease Prevention of the U.S. Department of Health and Human Services and the Armed Forces Epidemiology Board. His research, supported by the NIH, NSF, CDC, RWJF, explores how to use mobile, home and social technologies to measure and improve the health of individuals and populations.


Andrew Ries, MD, MPH is currently Associate Vice Chancellor for Academic Affairs and Professor of Medicine and Family Medicine and Public Health at the University of California, San Diego School of Medicine. Dr. Ries has maintained a career-long dedication to prevention and improving the health, well-being, and medical care of patients with chronic lung diseases. He directs the Pulmonary Rehabilitation Program at UCSD, one of the leading programs in the world, and has championed the cause of pulmonary rehabilitation as a standard of care for patients with disabling lung disease. He has had extensive experience in medical research directed toward improving the treatment, diagnosis, and evaluation of health outcomes in patients with chronic lung diseases. He chaired committees that published leading evidence-based guidelines reviewing and summarizing the scientific evidence establishing the basis of medical practice in pulmonary rehabilitation. He has been actively involved with state and national organizations including the American Lung Association, American Thoracic Society, American College of Chest Physicians, and American Association of Cardiovascular and Pulmonary Rehabilitation.

Dena Rifkin, MD, MS is an associate professor in the Division of Nephrology and the Division of Preventive Medicine. She received her MD degrees from Yale University and her master's in epidemiology from Tufts University. Her research interests include investigations of kidney disease and its associations with blood pressure patterns, medication use, and cognitive function. She has over 70 publications on these topics.




Cheryl Rock, PhD, RD, is a Professor in the Department of Family Medicine and Public Health, and the Cancer Prevention and Control Program, University of California, San Diego, School of Medicine. She completed undergraduate training in nutrition and dietetics at Michigan State University, achieved a Master of Medical Science degree in clinical nutrition at Emory University, and was awarded a doctoral degree in nutritional sciences from the University of California, Los Angeles. Dr. Rock’s research efforts are focused on the role of nutritional and dietary factors in the development and progression of cancer, particularly breast cancer, and healthy weight management in adults. Her research efforts address diet composition and weight management, and how diet, adiposity and physical activity affect biomarkers and disease risk and progression.  

Dr. Rock has been involved in several large trials funded by the National Institutes of Health (NIH) and the American Cancer Society, testing whether healthy weight control and modifications in diet and physical activity can alter biological processes, hormonal factors, body weight, progression of cancer, and cardiovascular disease risk factors.  Dr. Rock leads a clinical trial project and the biorepository core for the NIH-funded Transdisciplinary Research in Energetics and Cancer Center (TREC) at UCSD.   She also currently serves as PI of a clinical trial testing the effects of diet composition on weight loss, cardiovascular disease and cancer biomarkers, and meal satiety funded by the American Institute for Cancer Research and the California Walnut Commission.  Additionally, she is a co-investigator on NIH-funded studies that are focused on obesity, various weight loss interventions and strategies, and the behavioral and metabolic factors associated with disease risk.  Dr. Rock leads the Diet and Physical Activity Shared Resource of the Moores UCSD Comprehensive Cancer Center, a multifaceted laboratory, dietary and physical activity assessment, and behavioral counseling recharge service unit. 

Dr. Rock has served on numerous NIH and USDA review panels and committees, and she has served on editorial boards for several peer-reviewed journals.  To date, Dr Rock is the author of more than 245 scientific papers and book chapters.

Dorothy Sears - UC San Diego Family Medicine and Public HealthDorothy Sears, PhDis an Associate Professor with a primary appointment in the Department of Medicine, Division of Endocrinology & Metabolism and a secondary appointment in the Department of Family Medicine and Public Health, Division of Preventive Medicine.  She has been conducting obesity and type 2 diabetes-related research since 1995.  She is an internationally recognized expert in these fields, and has recently broadened her focus to include obesity-related cancer and disease prevention.  Her publications have been cited in >1500 research articles (Web of Knowledge).  Dr. Sears uses a variety of analytical approaches to identify and characterize genes, metabolites, and physiological pathways that are regulators and biomarkers of disease/disease risk and which can be used as novel targets for disease risk reduction, therapy, and/or diagnosis.  She is/has been Principal Investigator of clinical trials testing novel dietary and sedentary behavioral interventions for reducing chronic disease risk, a multi-site project assessing baseline and intervention-induced changes in breast cancer recurrence and mortality biomarkers, and a multi-site project assessing the lipid profiles in three mouse models of obesity-related cancer.  Dr. Sears is an Executive Committee member and the Basic Science Project Lead for the UCSD Women’s Cardiovascular Research Center. She is also a member of the UCSD FMPH Energy Balance, Obesity and Cancer Prevention Center of Excellence, the FMPH Women’s Health Center of Excellence, the Center for Circadian Biology, the Diabetes Research Center, and the Moores Cancer Center.  Dr. Sears is a faculty member of the UCSD Bioinformatics & Systems Biology Graduate Program.

UCSD School of Medicine & Health Sciences service:  Dr. Sears has served the School of Medicine as Chair of the Recruitment and Admissions Committee (RAC), and as a member of the Health Sciences Faculty Council, the Committee on Educational Policy, and the Core Curriculum Committee.  She currently serves on the Department of Medicine Committee on Academic Personnel, the RAC Executive Committee, and the Women in Health Sciences Committee (of which she is a co-founder). 


Community service: Dr. Sears actively supports the local and national American Diabetes Association (ADA).   She is currently President of the Greater San Diego ADA Community Leadership Board, and is a member of the Advocacy Committee and Speakers Bureau.  She has served as a grant reviewer for many agencies including the ADA, NIH, the Doris A. Howell Foundation, and the Christian Doppler Research Association.  Dr. Sears has been a member of the San Diego Chapter of the Association for Women in Science (AWIS-SD) since 2001 and had been very active in the leadership including serving as President (2010-2013).  Dr. Sears has been honored several times for her community service including the Greater San Diego Area American Diabetes Association ACT Advocacy Award (2015), the Women Making History - Eleanor Roosevelt Hero Award (2013), and the AWIS-SD Outstanding Volunteer Award (2009).

Email: dsears@ucsd.edu

Publications listed in Google Scholar profile: http://tinyurl.com/Sears-GoogleScholar

Yuyan Shi, PhD is a health policy analyst and health economist with research interests in policy and economic analysis of substance use and abuse. She obtained her Ph.D. degree in applied microeconomics and policy analysis with concentration on health economics from Pardee RAND Graduate School (RAND Corporation). She received master's degree in policy analysis from Tsinghua University, and Bachelor's degree from Peking University, China with double major in political science and economics. Before joining UCSD, she was a health economics consultant at the World Bank, and a health economist at the Healthways. Inc.

Dr. Shi’s current research concentrates on novel tobacco products and marijuana. She is interested in understanding the epidemiology and geographic patterns of drug use behaviors, evaluating the impacts of economics, environments, and policies in vulnerable subgroups and general population as a whole, and conducting economic evaluations to assess cost-effectiveness and cost-benefit of behavioral interventions. She is specialized in economics and statistical modeling, spatial analysis, and policy evaluation using large population data.

Dr. Shi teaches in the UCSD Bachelor of Science in Public Health (BSPH) on Health Policy and Healthy Lifestyles. She is also a guest lecturer in BSPH Introduction to Public Health and an instructor for undergraduate independent research.

Email: yus001@ucsd.edu



Google Scholar Profile: http://scholar.google.com/citations?user=7EQhcgUAAAAJ



Murray B Stein MD, MPH, FRCPC is Distinguished Professor of Psychiatry and Family Medicine & Public Health, and Vice Chair for Clinical Research in Psychiatry at the University of California San Diego (UCSD). He is also a Staff Psychiatrist at the VA San Diego Healthcare System. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, MD.

Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He is also interested in the relationship of mild traumatic brain injury (concussion) to mental disorders. He has written or co-written over 550 peer-reviewed scientific articles on these topics, including in journals such as Journal of the American Medical Association, New England Journal of Medicine, The Lancet, American Journal of Psychiatry, and JAMA Psychiatry. His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety and stress-related disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defense-funded (2008-2016) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2015) investigating risk factors for suicide, PTSD, TBI and other deployment-related disorders. This project is now in a longitudinal follow-up phase as STARRS-LS (2015-2019). He is also Co-Principal Proponent (with Joel Gelernter MD) of a VA Cooperative Genomewide Association Study of PTSD (2013-2017), in conjunction with the VA Million Veteran Program.

Dr. Stein is Co-Editor-in-Chief for UpToDate in Psychiatry, and Deputy Editor for the journal Biological Psychiatry.He is a member of the Scientific Advisory Board of the Anxiety and Depression Association of America (ADAA), and a Fellow of the American College of Neuropsychopharmacology (ACNP). Dr. Stein is a past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009), and was a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-2013). He is a past member of the Institute of Medicine (IOM) Board on the Health of Select Populations (2012-2015), and is currently a member of the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) (2011-2016).

C. Michael Wright, MD, FACC, DABCL is a voluntary professor in the Division of Preventive Medicine. He founded and headed the LifeScore Clinic from 1999-2007. The database of CT images and clinical data from the LifeScore Clinic has generated over 20 UCSD research papers on subclinical atherosclerosis in multiple vascular beds. Dr. Wright was the first physician in San Diego to offer coronary artery calcium screenings. The coronary artery calcium score has subsequently been proven to be the most accurate predictor of risk for heart attack. Recent papers have looked at the relationship of calcification in various arteries and mortality. Dr. Wright is board certified in Internal Medicine, Cardiovascular Disease and Clinical Lipidology. He is on staff at Scripps Memorial Hospital in La Jolla.


Page 'Breadcrumb' Navigation:

External Resources: